TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Karo Pharma Sverige AB
Closing information (x1000 SEK)
Closing information | 2021/12 | 2020/12 | 2019/12 |
Turnover | 276,924 | 228,725 | 293,539 |
Financial expenses | 345 | 126 | 153 |
Earnings before taxes | -16,320 | -12,443 | -1,062 |
EBITDA | -15,695 | -82,259 | 8,375 |
Total assets | 296,323 | 298,767 | 157,642 |
Current assets | 295,600 | 297,645 | 110,036 |
Current liabilities | 80,806 | 66,565 | 112,901 |
Equity capital | 215,517 | 232,096 | 44,635 |
- share capital | 157 | 157 | 157 |
Employees (average) | 129 | 93 | 40 |
Financial ratios
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Solvency | 72.7% | 77.7% | 28.3% |
Turnover per employee | 2,147 | 2,459 | 7,338 |
Profit as a percentage of turnover | -5.9% | -5.4% | -0.4% |
Return on assets (ROA) | -5.4% | -4.1% | -0.6% |
Current ratio | 365.8% | 447.1% | 97.5% |
Return on equity (ROE) | -7.6% | -5.4% | -2.4% |
Change turnover | 48,199 | -64,814 | 1,077 |
Change turnover % | 21% | -22% | 0% |
Chg. No. of employees | 36 | 53 | 11 |
Chg. No. of employees % | 39% | 133% | 38% |
Total value of public sale
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.